MICHELLE JENKINS: Open Payments
NPI 1386998102 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 13 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $179 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $331 |
| Gilead Sciences, Inc. | 1 | $21 |
Products named: REZDIFFRA.
Industry payments across DC — which companies pay providers there.
